Skip to content

Intel investor claim: what must a company disclose before a share offering?

16 November 2026Juriaan de Vries

Investor claims arising from a share offering

A listed company issuing new shares must give investors a reliable picture of its prospects. The US claim against Intel illustrates the difficulty of drawing that line: the company had already warned of a weaker PC market. The decisive questions are what was known about the extent of the downturn at the time and how the communications presented it.

Intel investors challenge the information given before the offering

On 13 November 2026, a US pension fund filed a class action against Intel, its chief executive officer and its chief financial officer. The case concerns purchases between 23 July and 29 October 2026. The claimant alleges that Intel gave an overly favourable account of the effects of weak PC sales and excess customer inventories. Its share price fell by almost 29% on 30 October, following the release of its quarterly results and outlook. The complaint filed on 13 November 2026 sets out the fund's allegations, which remain to be proved.

Between the challenged statements and the share-price fall, Intel issued new shares. The offering, completed on 12 August, raised gross proceeds of $23 billion at $95 per share. The original $20 billion offering was increased when the underwriting banks exercised their option to purchase additional shares. That timing makes the information provided before the offering particularly relevant (Intel, offering announcement, Item 8.01; October quarterly report, Note 4).

These US proceedings provide a starting point for examining Dutch disclosure duties. The comparison concerns a listed company subject to Dutch and European securities law. An investor's place of residence does not automatically make those rules applicable to their actual purchase of Intel shares.

Intel had already disclosed weaker PC demand

The original sources allow a more precise assessment than the broad allegation that Intel concealed a declining PC market. In its prepared remarks on its results of 23 July 2026, Intel had already forecast weaker PC sales in the second half of the year. It expected the PC market as a whole to decline by a low-double-digit percentage over the year. Alongside that outlook, it anticipated higher selling prices, a more favourable product mix and strong demand from data centres.

The quarterly report of 24 July 2026 also showed that the volume of PC products sold had fallen. Revenue grew because of higher average selling prices. A comparison of revenue figures alone would miss that development.

In October, Intel reported that higher component prices, constrained IT budgets and tighter inventory management were weighing on demand. The company expected further deterioration in the fourth quarter and continuing difficulties in 2027 (Intel, October 2026 quarterly report, pp. 31 and 33).

The legal question therefore turns to the relationship between the warnings and the reassurances. How serious was the sales problem known to be in July or August? And was there still a sound basis for expecting higher prices and other activities to offset those difficulties?

A prospectus must explain relevant adverse developments

Where a share offering requires a European prospectus, Article 6 of the Prospectus Regulation requires the information necessary for an informed assessment of matters including the issuer's financial position and prospects. Under Article 22 of that Regulation, advertising relating to the offering must also be consistent with the prospectus. Exemptions exist for some offerings, so the size of an offering alone does not determine which duties apply.

Intel did have a US prospectus. Its August 2026 prospectus supplement incorporated, among other documents, the second-quarter report by reference. It warned of changes in demand and margins, component shortages and share-price fluctuations. Those incorporated reports therefore form part of the information that must be assessed (prospectus supplement, pp. S-v and S-4 to S-7). The incorporated 2025 annual report also identified customer inventories, order cancellations and shortages that could prevent customers from assembling their own products (pp. 42 and 49). Those specific warnings must also be taken into account.

For the Dutch comparison, the question is how specific the warning needed to be. A general statement about a possible fall in demand may be insufficient where a materially more serious sales problem has already become established. The warning and the positive expectations must together give an accurate picture of the information available at the time. A subsequent disappointing result does not, by itself, prove a defect in the earlier prospectus.

The US claimant relies on the offering mainly to support the alleged motive for reassuring the market. Its complaint is based on US rules against misleading the securities market; it does not contain a separate claim for a misleading prospectus. The Dutch prospectus analysis is therefore an additional comparison here; see the complaint of 13 November 2026, paras 58 and 64-70.

Inside information may require an earlier warning

Alongside the prospectus requirements, a continuing disclosure duty applies. Under Articles 7 and 17 of the Market Abuse Regulation, an issuer must disclose inside information directly concerning it as soon as possible. This means sufficiently precise, non-public information likely to have a significant effect on the share price. An internal fluctuation or provisional calculation does not automatically meet that definition.

The exemption for intermediate steps in a protracted process, applicable since June 2026, does not give companies a general right to hold back a necessary profit warning until their quarterly results. The European supervisory authority ESMA clarified that profit warnings and unexpected changes in earnings may constitute inside information in their own right. Disclosure may therefore be required before the financial report is published (ESMA, answer of 8 October 2026).

Disclosure may be delayed subject to conditions. These include protecting legitimate interests and ensuring confidentiality. The information being withheld must also be consistent with the latest public communication on the same subject. An earlier reassuring message to the market may therefore make delay difficult to justify.

The evidence concerns what was known at the time

Dutch case law shows why the chronology matters. In the investor case against ING, the Amsterdam District Court dismissed the claims in 2025. Serious failings established later did not sufficiently prove what inside information had existed earlier. For the alleged breach of the disclosure duty, the investors had to state and prove the relevant facts, assessed against the information available at the time (Amsterdam District Court 2025, paras 6.3 and 6.19).

In Landis, by contrast, established earlier knowledge supported a finding of liability. A profit forecast was maintained when a loss ought to have been known. The Amsterdam District Court held in 2015 that the conduct of the former directors concerned met the threshold of a serious personal reproach. That judgment concerns directors' personal liability, which has its own threshold. It nevertheless illustrates how earlier knowledge can make an optimistic forecast legally untenable (Amsterdam District Court 2015, paras 4.3.1-4.3.3).

The currently available Intel complaint does not identify specific internal reports or employee statements supporting the alleged earlier knowledge. The claimant infers that knowledge mainly from public statements, the directors' positions and the importance of the PC business. It expects further evidence after obtaining access to internal documents. The crucial link therefore remains unresolved: what information had already made the reassurances untenable at the time?

What does this mean for investors and issuers?

A useful assessment compares three things at each relevant date: the public message, the information available internally and any discrepancy between them. For a share offering, that comparison includes the final prospectus, the reports incorporated into it and the accompanying communications. The broader evidential difficulty is also explored in the Philips investor claim.

Under the Dutch Civil Code (DCC), a breach of a disclosure duty for which the company is responsible may constitute an unlawful act (Section 6:162 DCC). The investor must then establish the connection between that breach, their purchase and their loss. The comparison is with their financial position had timely, accurate information been provided. The effects of the misleading information must therefore be distinguished from new adverse developments and other influences on the share price. The entire fall in market value does not automatically constitute recoverable loss. Whether to bring an individual investor claim requires a separate assessment.

For Intel, dated sales reports, customer inventory data and revised forecasts could be particularly significant. If they show that the expected offsets were already untenable before the offering, the allegation becomes specific. If the information available at the time still supported the expectations and the material deterioration became apparent only later, that weakens the claim. That missing comparison will determine the direction the case takes.

Frequently asked questions

Must an investor have read the prospectus personally?

Where a prospectus is misleading, a rebuttable presumption that the misleading information influenced the investment decision may assist the investor. Having read it personally is not a general requirement. The Supreme Court also took account of information reaching investors through advisers or the market. The existence and extent of the loss must be substantiated separately (Supreme Court 27 November 2009, paras 4.11.1-4.11.3).

Does AFM approval guarantee that an investment is sound?

The Netherlands Authority for the Financial Markets (AFM) assesses whether a prospectus is complete, comprehensible and consistent. AFM approval does not guarantee factual accuracy or amount to a recommendation of the shares. The issuer remains responsible for the information; business and share-price risks remain (Prospectus Regulation, Articles 2(r) and 20(4)).

Is an existing shareholder in the same position as a new buyer?

A buyer may have overpaid because of misleading information. An investor who merely held the same shares must substantiate a lost opportunity to sell. They must make a sufficiently plausible case that accurate information would have led them to act differently, with a real chance of a better outcome. This distinction was discussed when reviewing the Fortis settlement (Amsterdam Court of Appeal 2018, paras 5.26-5.29 and 5.33).

Cited case law

See also